University of Manchester

Low molecular weight heparin . MOA: inhibits factor Xa greater than IIa . Dosing: DVT prophylaxis: 40 mg QD or 30 mg BID . DVT treatment: 1 mg/Kg/dose Q12 hours or 1.5 mg/Kg/dose QD . Monitor: anti-Xa, platelets . Heparin: MOA: potentiates the action of antithrombin III & prevents the conversion of fibrinogen to fibrin . Dosing: ................
................